|
Powered by Cell Signaling Technology |
Site Information |
---|
ENAPLkSkMIyASSk SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 486689 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Relevant cell line - cell type - tissue: |
References | |
---|---|
Zhou J (2010) CST Curation Set: 9129; Year: 2010; Biosample/Treatment: cell line, ES J1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG)
Curated Info |
|
Guo A (2008) CST Curation Set: 4125; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: Alzheimer's disease; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG)
Curated Info |
|
Guo A (2008) CST Curation Set: 4127; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: Alzheimer's disease; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG)
Curated Info |
|
Guo A (2007) CST Curation Set: 3117; Year: 2007; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG)
Curated Info |